Riskpilot← Back to searchSign inGet full accessMaximus Medicus AB
ABActiveOrg 5591114235Linnea Andréns Väg 2Medical specialists activities · NACE 8622Est. 20171 employees
Revenue 2025
SEK 423K
+16% vs 2024
EBITDA margin
79.0%
+26% vs 2024
Equity ratio
75.7%
Financial strength
Net profit 2025
SEK 266K
+25% vs 2024
| Revenue | SEK 423K | +16% |
| EBITDA | SEK 334K | +26% |
| Net profit | SEK 266K | +25% |
| Total assets | SEK 767K | +25% |
| Equity | SEK 581K | +18% |
| Employees | 1 | — |
Legal name
Maximus Medicus AB
Org number
5591114235
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
8 maj 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet inom hälso- och sjukvård, både digitalt och fysiskt, inom både primärvård och specialistvård, samt kosmetik och estetik. Uthyrning av sjukvårdspersonal samt därmed förenlig verksamhet. Äga och förvalta fastigheter, bostäder, värdepapper, fordon och lös egendom samt därmed förenlig verksamhet.
Address
Linnea Andréns Väg 2
Email
dr.magnus@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 219 | 63 | 66 | 366 | 423 |
| Staff expenses | — | −29 | −8 | −17 | −30 |
| EBITDA | 111 | −23 | 25 | 266 | 334 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 111 | −23 | 25 | 266 | 334 |
| Net financials | — | 0 | 2 | 4 | 5 |
| Profit before tax | 111 | −23 | 27 | 269 | 339 |
| Tax | −24 | — | −2 | −58 | −73 |
| Net profit | 87 | −23 | 25 | 212 | 266 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 399 | 287 | 293 | 612 | 767 |
| Equity | 275 | 253 | 278 | 490 | 581 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 123 | 34 | 14 | 122 | 187 |
| Total debt | 123 | 34 | 14 | 122 | 187 |
EBITDA margin
79.0%
This company
15.8%
Market median
+400% vs market
20212025
Equity ratio
75.7%
This company
38.2%
Market median
+98% vs market
20212025
Return on equity
45.7%
This company
18.4%
Market median
+148% vs market
20212025
Net profit margin
62.8%
This company
8.1%
Market median
+675% vs market
20212025
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
20212025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Maximus Medicus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Daniel Raju Axefeldt | Board of Directors | 0 companies |
| Angela Maria Axefeldt | Deputy Board Member | 0 companies |